Antibiotics Market Size, Share & Trends Report

Antibiotics Market Size, Share & Trends Analysis Report By Drug Class (Cephalosporin, Penicillin, Fluoroquinolone, Macrolide, Carbapenem, Aminoglycoside, Sulfonamide, 7-ACA), By Action Mechanism, And Segment Forecasts, 2021 - 2028

Report ID: GVR-1-68038-149-8
Number of Pages: 120
Format: Electronic (PDF)

Historical Range: 2017 - 2019
Industry:Healthcare

Market segmentation

Antibiotics Action Mechanism Outlook (Revenue, USD Million, 2017 - 2028)
- Cell Wall Synthesis Inhibitors
- Protein Synthesis Inhibitors
- DNA Synthesis Inhibitors
- RNA Synthesis Inhibitors
- Mycolic Acid Inhibitors
- Others
Antibiotics Drug Class Outlook (Revenue, USD Million, 2017 - 2028)
- Cephalosporin
- Penicillin
- Fluoroquinolone
- Macrolide
- Carbapenem
- Aminoglycoside
- Sulfonamide
- 7-ACA
- Others
Antibiotics Regional Outlook (Revenue, USD Million, 2017 - 2028)
- North America
  - North America Antibiotics Market, By Action Mechanism
    - Cell Wall Synthesis Inhibitors
    - Protein Synthesis Inhibitors
    - DNA Synthesis Inhibitors
    - RNA Synthesis Inhibitors0
    - Mycolic Acid Inhibitors
    - Others
  - North America Antibiotics Market, By Drug Class
    - Cephalosporin
    - Penicillin
    - Fluoroquinolone
    - Macrolide
    - Carbapenem
    - Aminoglycoside
    - Sulfonamide
    - 7-ACA
    - Others
  - U.S.
    - U.S. Antibiotics Market, By Action Mechanism
      - Cell Wall Synthesis Inhibitors
      - Protein Synthesis Inhibitors
      - DNA Synthesis Inhibitors
      - RNA Synthesis Inhibitors
      - Mycolic Acid Inhibitors
      - Others
    - U.S. Antibiotics Market, By Drug Class
      - Cephalosporin
      - Penicillin
      - Fluoroquinolone
      - Macrolide
      - Carbapenem
      - Aminoglycoside
      - Sulfonamide
      - 7-ACA
      - Others
  - Canada
    - Canada Antibiotics Market, By Action Mechanism
      - Cell Wall Synthesis Inhibitors
      - Protein Synthesis Inhibitors
      - DNA Synthesis Inhibitors
      - RNA Synthesis Inhibitors
      - Mycolic Acid Inhibitors
      - Others
    - Canada Antibiotics Market, By Drug Class
      - Cephalosporin
      - Penicillin
      - Fluoroquinolone
      - Macrolide
      - Carbapenem
      - Aminoglycoside
      - Sulfonamide
      - 7-ACA
      - Others
- Europe
  - Europe Antibiotics Market, By Action Mechanism
    - Cell Wall Synthesis Inhibitors
    - Protein Synthesis Inhibitors
    - DNA Synthesis Inhibitors
    - RNA Synthesis Inhibitors
    - Mycolic Acid Inhibitors
    - Others
  - Europe Antibiotics Market, By Drug Class
    - Cephalosporin
    - Penicillin
    - Fluoroquinolone
    - Macrolide
    - Carbapenem
    - Aminoglycoside
    - Sulfonamide
    - 7-ACA
    - Others
  - U.K.
    - U.K. Antibiotics Market, By Action Mechanism
      - Cell Wall Synthesis Inhibitors
      - Protein Synthesis Inhibitors
      - DNA Synthesis Inhibitors
      - RNA Synthesis Inhibitors
      - Mycolic Acid Inhibitors
      - Others
    - U.K. Antibiotics Market, By Drug Class
      - Cephalosporin
      - Penicillin
      - Fluoroquinolone
      - Macrolide
      - Carbapenem
      - Aminoglycoside
      - Sulfonamide
      - 7-ACA
      - Others
  - Germany
    - Germany Antibiotics Market, By Action Mechanism
      - Cell Wall Synthesis Inhibitors
      - Protein Synthesis Inhibitors
      - DNA Synthesis Inhibitors
      - RNA Synthesis Inhibitors
      - Mycolic Acid Inhibitors
      - Others
    - Germany Antibiotics Market, By Drug Class
      - Cephalosporin
      - Penicillin
      - Fluoroquinolone
      - Macrolide
      - Carbapenem
      - Aminoglycoside
      - Sulfonamide
      - 7-ACA
      - Others
  - France
    - France Antibiotics Market, By Action Mechanism
      - Cell Wall Synthesis Inhibitors
      - Protein Synthesis Inhibitors
      - DNA Synthesis Inhibitors
      - RNA Synthesis Inhibitors
      - Mycolic Acid Inhibitors
      - Others
    - France Antibiotics Market, By Drug Class
      - Cephalosporin
      - Penicillin
      - Fluoroquinolone
      - Macrolide
      - Carbapenem
      - Aminoglycoside
      - Sulfonamide
      - 7-ACA
      - Others
  - Spain
    - Spain Antibiotics Market, By Action Mechanism
      - Cell Wall Synthesis Inhibitors
      - Protein Synthesis Inhibitors
      - DNA Synthesis Inhibitors
      - RNA Synthesis Inhibitors
      - Mycolic Acid Inhibitors
      - Others
    - Spain Antibiotics Market, By Drug Class
      - Cephalosporin
      - Penicillin
      - Fluoroquinolone
      - Macrolide
      - Carbapenem
      - Aminoglycoside
      - Sulfonamide
      - 7-ACA
      - Others
  - Italy
    - Italy Antibiotics Market, By Action Mechanism
      - Cell Wall Synthesis Inhibitors
      - Protein Synthesis Inhibitors
      - DNA Synthesis Inhibitors
      - RNA Synthesis Inhibitors
      - Mycolic Acid Inhibitors
      - Others
    - Italy Antibiotics Market, By Drug Class
      - Cephalosporin
      - Penicillin
      - Fluoroquinolone
      - Macrolide
      - Carbapenem
      - Aminoglycoside
      - Sulfonamide
      - 7-ACA
      - Others
- Asia Pacific
  - Asia Pacific Antibiotics Market, By Action Mechanism
    - Cell Wall Synthesis Inhibitors
    - Protein Synthesis Inhibitors
    - DNA Synthesis Inhibitors
    - RNA Synthesis Inhibitors
    - Mycolic Acid Inhibitors
    - Others
  - Asia Pacific Antibiotics Market, By Drug Class
    - Cephalosporin
    - Penicillin
    - Fluoroquinolone
    - Macrolide
    - Carbapenem
    - Aminoglycoside
    - Sulfonamide
    - 7-ACA
    - Others
  - Japan
    - Japan Antibiotics Market, By Action Mechanism
      - Cell Wall Synthesis Inhibitors
      - Protein Synthesis Inhibitors
      - DNA Synthesis Inhibitors
      - RNA Synthesis Inhibitors
      - Mycolic Acid Inhibitors
      - Others
    - Japan Antibiotics Market, By Drug Class
      - Cephalosporin
      - Penicillin
      - Fluoroquinolone
      - Macrolide
      - Carbapenem
      - Aminoglycoside
      - Sulfonamide
      - 7-ACA
      - Others
  - China
    - China Antibiotics Market, By Action Mechanism
      - Cell Wall Synthesis Inhibitors
      - Protein Synthesis Inhibitors
      - DNA Synthesis Inhibitors
      - RNA Synthesis Inhibitors
      - Mycolic Acid Inhibitors
      - Others
    - China Antibiotics Market, By Drug Class
      - Cephalosporin
      - Penicillin
      - Fluoroquinolone
      - Macrolide
      - Carbapenem
      - Aminoglycoside
      - Sulfonamide
      - 7-ACA
      - Others
  - India
    - India Antibiotics Market, By Action Mechanism
      - Cell Wall Synthesis Inhibitors
      - Protein Synthesis Inhibitors
      - DNA Synthesis Inhibitors
      - RNA Synthesis Inhibitors
      - Mycolic Acid Inhibitors
      - Others
    - India Antibiotics Market, By Drug Class
      - Cephalosporin
      - Penicillin
      - Fluoroquinolone
      - Macrolide
      - Carbapenem
      - Aminoglycoside
      - Sulfonamide
      - 7-ACA
      - Others
  - South Korea
    - South Korea Antibiotics Market, By Action Mechanism
      - Cell Wall Synthesis Inhibitors
      - Protein Synthesis Inhibitors
      - DNA Synthesis Inhibitors
      - RNA Synthesis Inhibitors
      - Mycolic Acid Inhibitors
      - Others
    - 韩国抗生素市场,药品类
      - Cephalosporin
      - Penicillin
      - Fluoroquinolone
      - Macrolide
      - Carbapenem
      - Aminoglycoside
      - Sulfonamide
      - 7-ACA
      - Others
  - Thailand
    - Thailand Antibiotics Market, By Action Mechanism
      - Cell Wall Synthesis Inhibitors
      - Protein Synthesis Inhibitors
      - DNA Synthesis Inhibitors
      - RNA Synthesis Inhibitors
      - Mycolic Acid Inhibitors
      - Others
    - Thailand Antibiotics Market, By Drug Class
      - Cephalosporin
      - Penicillin
      - Fluoroquinolone
      - Macrolide
      - Carbapenem
      - Aminoglycoside
      - Sulfonamide
      - 7-ACA
      - Others
- Latin America
  - Latin America Antibiotics Market, By Action Mechanism
    - Cell Wall Synthesis Inhibitors
    - Protein Synthesis Inhibitors
    - DNA Synthesis Inhibitors
    - RNA Synthesis Inhibitors
    - Mycolic Acid Inhibitors
    - Others
  - Latin America Antibiotics Market, By Drug Class
    - Cephalosporin
    - Penicillin
    - Fluoroquinolone
    - Macrolide
    - Carbapenem
    - Aminoglycoside
    - Sulfonamide
    - 7-ACA
    - Others
  - Brazil
    - Brazil Antibiotics Market, By Action Mechanism
      - Cell Wall Synthesis Inhibitors
      - Protein Synthesis Inhibitors
      - DNA Synthesis Inhibitors
      - RNA Synthesis Inhibitors
      - Mycolic Acid Inhibitors
      - Others
    - Brazil Antibiotics Market, By Drug Class
      - Cephalosporin
      - Penicillin
      - Fluoroquinolone
      - Macrolide
      - Carbapenem
      - Aminoglycoside
      - Sulfonamide
      - 7-ACA
      - Others
  - Mexico
    - Mexico Antibiotics Market, By Action Mechanism
      - Cell Wall Synthesis Inhibitors
      - Protein Synthesis Inhibitors
      - DNA Synthesis Inhibitors
      - RNA Synthesis Inhibitors
      - Mycolic Acid Inhibitors
      - Others
    - Mexico Antibiotics Market, By Drug Class
      - Cephalosporin
      - Penicillin
      - Fluoroquinolone
      - Macrolide
      - Carbapenem
      - Aminoglycoside
      - Sulfonamide
      - 7-ACA
      - Others
  - Argentina
    - Argentina Antibiotics Market, By Action Mechanism
      - Cell Wall Synthesis Inhibitors
      - Protein Synthesis Inhibitors
      - DNA Synthesis Inhibitors
      - RNA Synthesis Inhibitors
      - Mycolic Acid Inhibitors
      - Others
    - Argentina Antibiotics Market, By Drug Class
      - Cephalosporin
      - Penicillin
      - Fluoroquinolone
      - Macrolide
      - Carbapenem
      - Aminoglycoside
      - Sulfonamide
      - 7-ACA
      - Others
- Middle East & Africa
  - Middle East & Africa Antibiotics Market, By Action Mechanism
    - Cell Wall Synthesis Inhibitors
    - Protein Synthesis Inhibitors
    - DNA Synthesis Inhibitors
    - RNA Synthesis Inhibitors
    - Mycolic Acid Inhibitors
    - Others
  - Middle East & Africa Antibiotics Market, By Drug Class
    - Cephalosporin
    - Penicillin
    - Fluoroquinolone
    - Macrolide
    - Carbapenem
    - Aminoglycoside
    - Sulfonamide
    - 7-ACA
    - Others
  - 南部非洲的a
    - 南部非洲的a Antibiotics Market, By Action Mechanism
      - Cell Wall Synthesis Inhibitors
      - Protein Synthesis Inhibitors
      - DNA Synthesis Inhibitors
      - RNA Synthesis Inhibitors
      - Mycolic Acid Inhibitors
      - Others
    - 南部非洲的a Antibiotics Market, By Drug Class
      - Cephalosporin
      - Penicillin
      - Fluoroquinolone
      - Macrolide
      - Carbapenem
      - Aminoglycoside
      - Sulfonamide
      - 7-ACA
      - Others
  - Saudi Arabia
    - Saudi Arabia Antibiotics Market, By Action Mechanism
      - Cell Wall Synthesis Inhibitors
      - Protein Synthesis Inhibitors
      - DNA Synthesis Inhibitors
      - RNA Synthesis Inhibitors
      - Mycolic Acid Inhibitors
      - Others
    - Saudi Arabia Antibiotics Market, By Drug Class
      - Cephalosporin
      - Penicillin
      - Fluoroquinolone
      - Macrolide
      - Carbapenem
      - Aminoglycoside
      - Sulfonamide
      - 7-ACA
      - Others
  - UAE
    - UAE Antibiotics Market, By Action Mechanism
      - Cell Wall Synthesis Inhibitors
      - Protein Synthesis Inhibitors
      - DNA Synthesis Inhibitors
      - RNA Synthesis Inhibitors
      - Mycolic Acid Inhibitors
      - Others
    - UAE Antibiotics Market, By Drug Class
      - Cephalosporin
      - Penicillin
      - Fluoroquinolone
      - Macrolide
      - Carbapenem
      - Aminoglycoside
      - Sulfonamide
      - 7-ACA
      - Others

Report content

Qualitative Analysis

Industry overview
Industry trends
Market drivers and restraints
乐鱼体育手机网站入口
Growth prospects
Porter’s analysis
PESTEL analysis
Key market opportunities prioritized
Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments

Quantitative Analysis

Market size, estimates, and forecast from 2017 to 2028
Market estimates and forecast for product segments up to 2028
Regional market size and forecast for product segments up to 2028
Market estimates and forecast for application segments up to 2028
Regional market size and forecast for application segments up to 2028
Company financial performance

GET A FREE SAMPLE

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

Or view our licence options:

NEED A CUSTOM REPORT?

We can customize every report -free of charge- including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

ESOMAR certified & member

Leading SME award by D&B

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read ourprivacy policy.